Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1743-422X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype ; volume:13 ; number:1 ; day:18 ; month:4 ; year:2016 ; pages:1-12 ; date:12.2016
Virology journal ; 13, Heft 1 (18.4.2016), 1-12, 12.2016
- Urheber
-
Bhardwaj, Suvercha
- Beteiligte Personen und Organisationen
-
Ahmad, Fareed
Wedemeyer, Heiner
Cornberg, Marcus
Schulze zur Wiesch, Julian
van Lunzen, Jan
Sarin, Shiv K.
Schmidt, Reinhold E.
Meyer-Olson, Dirk
SpringerLink (Online service)
- DOI
-
10.1186/s12985-016-0507-5
- URN
-
urn:nbn:de:1111-201604202715
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bhardwaj, Suvercha
- Ahmad, Fareed
- Wedemeyer, Heiner
- Cornberg, Marcus
- Schulze zur Wiesch, Julian
- van Lunzen, Jan
- Sarin, Shiv K.
- Schmidt, Reinhold E.
- Meyer-Olson, Dirk
- SpringerLink (Online service)
Ähnliche Objekte (12)
HIV-HCV Co-infection Among Blood Donors
Characterization of NK cell immunity in chronic HCV infection
HCV co-infection in HIV positive population in British Columbia, Canada
Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
HCV co-infection is related to acute ischemic severity and outcome
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
HCV-specific T cell responses during and after chronic HCV infection
Managing HCV infection: present and future
Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection
HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic
HIV-HCV Co-infection Among Blood Donors
Characterization of NK cell immunity in chronic HCV infection
HCV co-infection in HIV positive population in British Columbia, Canada
Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
HCV co-infection is related to acute ischemic severity and outcome
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
HCV-specific T cell responses during and after chronic HCV infection
Managing HCV infection: present and future
Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection
HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic
HIV-HCV Co-infection Among Blood Donors
Characterization of NK cell immunity in chronic HCV infection
HCV co-infection in HIV positive population in British Columbia, Canada
Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
HCV co-infection is related to acute ischemic severity and outcome
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
HCV-specific T cell responses during and after chronic HCV infection
Managing HCV infection: present and future
Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection
HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination